A Phase 1, Open-Label, Multicenter Study of INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

Project: Research

Project Details

StatusActive
Effective start/end date12/09/23 → 12/09/26

Keywords

  • clinical trial
  • haematological malignancy
  • Myeloproliferative Neoplasms

Clinical Trial Phase

  • Phase I